selected scholarly activity
-
conferences
- P.4.a.008 A randomized placebo controlled trial of olanzapine in trichotillomania. European Neuropsychopharmacology. S452-S452. 2006
- A pilot study of topiramate augmentation in treatment resistant obsessive-compulsive disorder. European Neuropsychopharmacology. S553-S554. 2005
- Topiramate augmentation in a case series of treatment resistant obsessive compulsive disorder. International Journal of Neuropsychopharmacology. S368-S368. 2004
- Topiramate in generalized social phobia: An open trial. International Journal of Neuropsychopharmacology. S371-S371. 2004
-
journal articles
- A Randomized, Double-Blind, Placebo-Controlled Trial of Olanzapine in the Treatment of Trichotillomania. Journal of Clinical Psychiatry. 71:1336-1343. 2010
- The Prevalence of Migraine Headaches in an Anxiety Disorders Clinic Sample. CNS Neuroscience and Therapeutics. 16:76-82. 2010
- Symptom relapse following switch from Celexa to generic citalopram: an anxiety disorders case series. Journal of Psychopharmacology. 21:472-476. 2007
- Nefazodone in the Treatment of Generalized Social Phobia. Journal of Clinical Psychiatry. 68:288-295. 2007
- Topiramate augmentation in treatment-resistant obsessive–compulsive disorder: a retrospective, open-label case series. Depression and Anxiety. 23:1-5. 2006
- Emerging Treatments for Child and Adolescent Social Phobia: AReview. Journal of Child and Adolescent Psychopharmacology. 15:589-607. 2005
- An evaluation of paroxetine in generalised social anxiety disorder. Expert Opinion on Pharmacotherapy. 6:819-830. 2005
- An Open Trial of Topiramate in the Treatment of Generalized Social Phobia. Journal of Clinical Psychiatry. 65:1674-1678. 2004
- Optimizing Treatment in Social Phobia: A Review of Treatment Resistance. CNS Spectrums. 9:753-762. 2004
- Antiepileptic Drugs in the Treatment of Anxiety Disorders. Drugs. 64:2199-2220. 2004